Before the outbreak of the pandemic, the use of telemedicine it was optional. However, the Covid made it a necessity and has led to a change in the behavior of patients.
“When we talk about the use of devices to promote digital health, the first wearable is the mobile device. Large technology companies and manufacturers already add capabilities to phones that allow measuring certain things, “he explained. Pedro Diaz Yuste, CEO of Savia.
The first medical device is the mobile, but not the only one. And, as Díaz explained in the ‘II Health Observatory Symposium: The Lessons of Covid-19’, organized by EL ESPAÑOL and Invertia, there are already clocks that measure your blood oxygen saturation.
Telemedicine is making its way with the arrival of mobile devices that measure vital signs. And it will make even diagnostic equipment disappear. White angel, Corporate Director of Organization, Processes and ICT of the Quironsalud group, has given the dermatoscope as an example because now “the patient sends the doctor a photo taken with the mobile phone”.
And not only will this team disappear, the microscope has already done it: “We removed them from some of our centers and today it is diagnosed without it.”
The pandemic “has introduced us to the greatest change in the history of medicine and the protagonist of this change is the patient who now demands a service,” added Blanco.
And that also means a change in the healthcare model. “The first consultation has to be to start treatment and not to request tests. We have verified that 70% of face-to-face consultations are useless and we must end this, “he continued.
The management and use of data has been another of the issues addressed by the speakers at this table. The CEO of Savia recalled that “technology allows us to store them, use them and make decisions in real time. But we have to take it seriously because it is very intimate data.”
In this sense, Díaz Yuste points in two directions. On the one hand, the transparency, that is, “make the user aware of what type of information he shares and what we use it for”.
On the other, the control, that is to say, that “the patient has to be very easy to say ‘I no longer want to share information'”.
And, as Blanco recalled, “what is important with the data is not what we know, it is what we do with it.”
Follow the topics that interest you